Stock Info Nets

Independent Financial Information Made Easy

Our AI creates

The Best Stock Graphs and Charts

Youtube Subscribe Blog GamificArt

The development of Artificial Intelligence (AI) is modifying the way investments are evaluated. We programmed an artificial intelligence (A.I.) to summarize the whole internet. Whether you’re trying to make money investing online, making financial decisions or just getting informed about Wall Street, this page is a way to get informed without reading hundred of pages. Our stock market summary graphs are produced using machine learning, an unbiased view to capture what internet is saying. Usually, the AI reads several hundred pages and summarize it to a short text and several charts.

September 24, 2023 10:35 (London Time)

Seagen

Youtube Subscribe

...

Sector: Biotechnology
Ticker: SGEN
Sentiment: -0.6597
MarketCap: 38,738,976,804.0
High: 214.0 Low: 213.2

Open: 213.8 Close: 213.7 Change: -0.1

Don't invest in Seagen Stock before reading this automated analysis produce by an AI.

This document will help you to evaluate Seagen without reading an infinite amount of sources. Relying only on stock quotes or prices to make investment decisions is a mistake. Analyzing and observing stock charts, highs and lows and other numerical data does not allow to evaluate the real value of a company. Stock quotes and prices are the result of underlying characteristics of a company and of events and news happening around them. For this reason, investing must be based on information, not numbers. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Seagen are: Seagen, clinical, Merck, cancer, positive, result, Phase, and the …

Concept Map

...

Semantic Network

...

Stock Summary

Seagen Inc. develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company also develops TIVDAK for metastatic cervical cancer and other solid tumors. It has collaboration agreements with Takeda.

Today's Summary

Federal Trade Commission is asking for more information regarding Pfizers planned $43 billion acquisition of Seagen. Seagen Inc. up $7.31 to $213.70.

Today's News

Seagen and Astellas entered a clinical collaboration agreement with Merck to evaluate the combination of PADCEV (enfortumab vedotin-ejfv) and Mercks KEYTRUDA (pembrolizumab) in patients with previously untreated metastatic urothelial cancer. Seagen is headquartered in Bothell, Washington. Merckounces positive results from the KEYA Phase 3A clinical trial conducted in Canada and the U.S. Merck announces positive results in Phase 3-A of KEYA, which was conducted in the 3.39/39/302/302. Merck announced positive to date results from Phase 3 of the KeyA 3-39, which is a cancer drug with additional clinical trials of chemoatresprovided vocal emulator +++ postersidishea BrightDersle Calcul Penenvironmentussions Seagen, Nurix team to create new class of Antibody Conjugates for Cancer. Federal Trade Commission is asking for more information regarding Pfizers planned $43 billion acquisition of Seagen. Seagen Inc. up $7.31 to $213.70. Seagen jumps as combination therapy succeeds in bladder cancer trial. Seagen (NASDAQ:SGEN – Get Free Report ) last announced its quarterly earnings data on Wednesday, August 2nd. Seagen had a negative net margin of 33.54% and a negative return on equity of 26.46% As a group, sell-side analysts forecast that Seagen Inc. will be outperforming as a group.

Stock Profile

"Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. It offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment of adult patients with advanced or metastatic urothelial cancer; and TUKYSA, an oral small molecule tyrosine kinase inhibitor for the treatment of adult patients with advanced unresectable or metastatic HER2-positive breast cancer. The company also develops TIVDAK for metastatic cervical cancer and other solid tumors; Ladiratuzumab Vedotin, an ADC targeting LIV-1 for metastatic breast cancer and solid tumors; Disitamab Vedotin, a novel HER2-targeted ADC; and SEA-TGT and SEA-CD70 for various cancer diseases. It has collaboration agreements with Takeda Pharmaceutical Company Limited; Agensys, Inc.; Genmab A/S; Merck; and RemeGen, Co. Ltd. The company was formerly known as Seattle Genetics, Inc. and changed its name to Seagen Inc. in October 2020. Seagen Inc. was incorporated in 1997 and is headquartered in Bothell, Washington."

Keywords

How much time have you spent trying to decide whether investing in Seagen? Many investors start with the dream of being free. They expect to find on the stock market an option to have time to develop their own interests and hobbies. That is, a way to escape a 9 to 5 job. However, investment is complex and investors end up spending whole days (and nights) trying to figure out which the right stock to invest is. The dream of stock investing becomes the nightmare of facing infinity amounts of information. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Seagen are: Seagen, clinical, Merck, cancer, positive, result, Phase, and the most common words in the summary are: seagen, job, best, news, inc, stock, bloomberg, . One of the sentences in the summary was: up $7.31 to $213.70.. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #seagen #job #best #news #inc #stock #bloomberg.

Read more →

Related Results

...
December 16, 2023 8:43 (London Time)

Seagen

Pfizer to close $43 billion seagen acquisition this week - marketwatch.com.com. Pfizer expects to close the acquisition of Seagen on December 14. Th…
Sector: Biotechnology
Ticker: SGEN
Sentiment: 0.946
MarketCap: 43,154,699,593.0
High: 228.74 Low: 228.74

Open: 228.74 Close: 228.74 Change: 0.0

Read more →
...
December 07, 2023 9:23 (London Time)

Seagen

Seagen rose 1.3% amid some bullish options trades and optimism that the Federal Trade Commission could approve its planned $43 billon sale. Pfizer a…
Sector: Biotechnology
Ticker: SGEN
Sentiment: 0.9081
MarketCap: 40,713,404,617.0
High: 216.42 Low: 215.28

Open: 216.11 Close: 215.8 Change: -0.31

Read more →
...
October 12, 2023 10:59 (London Time)

Seagen

Federal Trade Commission and European Commission are reviewing Pfizers planned $43 billion acquisition of cancer drug maker Seagen. Seagen expects t…
Sector: Biotechnology
Ticker: SGEN
Sentiment: -0.9063
MarketCap: 40,261,207,057.0
High: 214.83 Low: 214.11

Open: 214.62 Close: 214.5 Change: -0.12

Read more →
...
September 14, 2023 23:28 (London Time)

Seagen

Pfizer is reportedly in talks to buy the cancer drugmaker. Pfizer reportedly in negotiations to buy Seagen. Seagen currently has a consensus rating …
Sector: Biotechnology
Ticker: SGEN
Sentiment: -0.872
MarketCap: 38,654,512,733.0
High: 207.17 Low: 206.0

Open: 206.0 Close: 206.5 Change: 0.5

Read more →
...
August 05, 2023 14:26 (London Time)

Seagen

Pfizer expects Seagen deal to close in late 2023 or early 2024. Pfizer expected to generate about $2.2 bln of revenue. Seagen is headquartered in Se…
Sector: Biotechnology
Ticker: SGEN
Sentiment: 0.9792
MarketCap: 36,085,140,758.0
High: 194.42 Low: 193.44

Open: 193.69 Close: 193.47 Change: -0.22

Read more →
...
June 27, 2023 1:21 (London Time)

Seagen

Seagen Inc. reports financial results for first quarter ended March 31, 2023. Seagen revenue was $1.96 billion, an increase of 24.65% compared to th…
Sector: Biotechnology
Ticker: SGEN
Sentiment: 0.8417
MarketCap: 37,167,038,717.0
High: 198.4 Low: 196.43

Open: 198.0 Close: 196.54 Change: -1.46

Read more →
...
December 15, 2023 8:06 (London Time)

Seagen

Pfizer-Seagen merger is the largest M&A deal in biopharma since AbbVie acquired Allergan for $63 billion in June 2019. European Commission on Thursd…
Sector: Biotechnology
Ticker: SGEN
Sentiment: -0.5574
MarketCap: 43,154,699,593.0
High: 228.74 Low: 228.74

Open: 228.74 Close: 228.74 Change: 0.0

Read more →
...
December 05, 2023 0:40 (London Time)

Seagen

Pfizer CFO reiterates Seagen closing expected later this year, early next year. European antitrust regulator approved purchase last month. FDA grant…
Sector: Biotechnology
Ticker: SGEN
Sentiment: 0.765
MarketCap: 40,132,323,587.0
High: 213.24 Low: 212.52

Open: 212.72 Close: 213.13 Change: 0.41

Read more →
...
September 24, 2023 10:35 (London Time)

Seagen

Federal Trade Commission is asking for more information regarding Pfizers planned $43 billion acquisition of Seagen. Seagen Inc. up $7.31 to $213.70.
Sector: Biotechnology
Ticker: SGEN
Sentiment: -0.6597
MarketCap: 38,738,976,804.0
High: 214.0 Low: 213.2

Open: 213.8 Close: 213.7 Change: -0.1

Read more →
...
August 12, 2023 15:42 (London Time)

Seagen

Seagen stock last closed at $194.68, down 0.16% from the previous day, and has increased 11.86% in one year. Seagen has a fifty-two week low of $116…
Sector: Biotechnology
Ticker: SGEN
Sentiment: 0.7579
MarketCap: 36,601,097,325.0
High: 195.75 Low: 194.42

Open: 194.66 Close: 194.68 Change: 0.02

Read more →
...
July 04, 2023 22:28 (London Time)

Seagen

Seagen Inc. (Nasdaq: SGEN) reported financial results today for the first quarter ended March 31, 20.9% on a year-over-year basis. Pfizer agreed in …
Sector: Biotechnology
Ticker: SGEN
Sentiment: 0.9666
MarketCap: 36,087,015,798.0
High: 194.44 Low: 192.25

Open: 192.9 Close: 194.43 Change: 1.53

Read more →
...
May 22, 2023 22:29 (London Time)

Seagen

Pfizer to raise $31 billion for seagen deal in debt offering. Pfizer expects to complete the $43 billion Seagen buyout later this year or in early 2…
Sector: Biotechnology
Ticker: SGEN
Sentiment: -0.9838
MarketCap: 37,500,795,800.0
High: 193.9 Low: 192.3

Open: 193.66 Close: 193.36 Change: -0.3

Read more →